Live Price
Live Volume
Corcept Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $110.82 |
|---|---|
| Close | $110.82 |
| Low | $110.82 |
| Low Change | 0.00 (0.00%) |
| High | $110.82 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 411.632K |
| Dollar Volume | $45.62M |
Regular Trading Hours
| Open | $111.97 |
|---|---|
| Close | $110.82 |
| Low | $109.40 |
| Low Change | -2.57 (-2.30%) |
| High | $112.80 |
| High Change | +0.83 (+0.74%) |
| Range | $3.40 |
| Volume | 768.995K |
| Dollar Volume | $85.22M |
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $111.80 |
|---|---|
| Close | $111.80 |
| Low | $111.80 |
| Low Change | 0.00 (0.00%) |
| High | $111.80 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 462.674K |
| Dollar Volume | $51.73M |
Regular Trading Hours Yesterday
| Open | $113.38 |
|---|---|
| Close | $111.82 |
| Low | $111.10 |
| Low Change | -2.28 (-2.01%) |
| High | $114.52 |
| High Change | +1.14 (+1.01%) |
| Range | $3.42 |
| Volume | 694.73K |
| Dollar Volume | $77.68M |
Premarket Yesterday
*No Trades in Segment
Corcept Therapeutics News
2 months agobarrons.comS&P 500 Futures Rise in Premarket Trading; Corcept Therapeutics, FormFactor Lead
6 months agoinvesting.comCorcept Therapeutics stock surges on FDA cancer drug approval
6 months agoinvesting.comCorcept Therapeutics stock gains after director stock purchase
7 months agoinvesting.comCorcept Therapeutics stock falls after losing key patent case appeal
8 months agoinvesting.comCorcept Therapeutics stock soars after cancer drug meets survival endpoint
9 months agoinvesting.comCorcept Therapeutics stock plunges after FDA rejects hypercortisolism drug
9 months agobenzinga.comCorcept Therapeutics' Upcoming FDA Decision: Is A CRL Likely?
Corcept Therapeutics Top Trades
Corcept Therapeutics's top trade so far today returned +1.30%, while the top short trade returned -2.30%.
Corcept Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $113.81 |
|---|---|
| 10 Day Moving Average (SMA10) | $113.08 |
| 20 Day Moving Average (SMA20) | $116.29 |
| 50 Day Moving Average (SMA50) | $106.65 |
| 100 Day Moving Average (SMA100) | $86.49 |
| 200 Day Moving Average (SMA200) | $67.76 |
Corcept Therapeutics Statistics
| Average Volume (30 Days) | 898.52K |
|---|---|
| P/E Ratio (Current) | 225.58 |
| EPS (Current) | $0.50 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $106.92M |
| Cash Ratio | 0.72 |
| Current Ratio | 2.86 |
| Quick Ratio | 2.77 |
| Debt to Equity | 0.00 |
| Enterprise Value | $12.08B |
| EV to EBITDA | 1430.76 |
| EV to Sales | 14.54 |
| Price to Book | 17.28 |
| Price to Cash Flow | 111.14 |
| Price to Free Cash Flow | 114.03 |
| Price to Sales | 14.68 |
| Return on Assets | 0.06% |
| Return on Equity | 0.08% |
Corcept Therapeutics Stock Splits
There have been no stock splits for Corcept Therapeutics (CORT).
Corcept Therapeutics Dividends
There have been no dividends for Corcept Therapeutics (CORT).